Precision Treatment Becomes a New Trend Mr. Jiang’s case is a microcosm of the Department of Cardiology at Shulan Hospital exploring precision treatment for cardiovascular diseases. In recent years, with the development of medical technology, the treatment of cardiovascular diseases has evolved from traditional "symptomatic treatment" to the "targeted treatment era," bringing new hope to more patients.

"Currently, our team is capable of performing almost all the world’s most advanced cardiovascular interventional diagnosis and treatment technologies, striving to provide comprehensive treatment guarantees for patients with various high-risk, difficult, and complex cardiovascular diseases," said Fu Guosheng.

Zhou Zhou from Guangxi is a patient with severe β-thalassemia. After 16 years of blood transfusion, she and her family decided to undergo hematopoietic stem cell transplantation (HSCT). In 2021, the soon-to-be 17-year-old Zhou Zhou found the team led by Director Liao Jianyun. After two years of continuous iron chelation therapy, she underwent HSCT at Southern Chunfu (Children's) Institute of Hematology, Gobroad Medical (Hematology) Guangdong Research Center in 2023.